Sugi Holdings Co.,Ltd. (SGIPF)
OTCMKTS · Delayed Price · Currency is USD
16.29
0.00 (0.00%)
Aug 22, 2025, 4:00 PM EDT
Sugi Holdings Revenue
Sugi Holdings had revenue of 245.46B JPY in the quarter ending May 31, 2025, with 22.14% growth. This brings the company's revenue in the last twelve months to 922.52B, up 20.18% year-over-year. In the fiscal year ending February 28, 2025, Sugi Holdings had annual revenue of 878.02B with 17.94% growth.
Revenue (ttm)
922.52B JPY
Revenue Growth
+20.18%
P/S Ratio
0.77
Revenue / Employee
78.05M JPY
Employees
11,820
Market Cap
4.95B USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Feb 28, 2025 | 878.02B | 133.54B | 17.94% |
Feb 29, 2024 | 744.48B | 76.83B | 11.51% |
Feb 28, 2023 | 667.65B | 42.17B | 6.74% |
Feb 28, 2022 | 625.48B | 22.97B | 3.81% |
Feb 28, 2021 | 602.51B | 60.55B | 11.17% |
Feb 29, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Feb 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Feb 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Feb 29, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Glass House Brands | 221.55M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 105.45M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.09M |
Silence Therapeutics | 27.17M |
Global Cord Blood | 196.10M |